IL165511A0 - A process for preparing sulfoxide compounds compounds prepared thereby and pharmaceutical compositions containing the same - Google Patents

A process for preparing sulfoxide compounds compounds prepared thereby and pharmaceutical compositions containing the same

Info

Publication number
IL165511A0
IL165511A0 IL16551104A IL16551104A IL165511A0 IL 165511 A0 IL165511 A0 IL 165511A0 IL 16551104 A IL16551104 A IL 16551104A IL 16551104 A IL16551104 A IL 16551104A IL 165511 A0 IL165511 A0 IL 165511A0
Authority
IL
Israel
Prior art keywords
compounds
pharmaceutical compositions
same
compositions containing
preparing sulfoxide
Prior art date
Application number
IL16551104A
Other languages
English (en)
Original Assignee
Reddys Lab Inc Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Inc Dr filed Critical Reddys Lab Inc Dr
Publication of IL165511A0 publication Critical patent/IL165511A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL16551104A 2002-06-27 2004-12-02 A process for preparing sulfoxide compounds compounds prepared thereby and pharmaceutical compositions containing the same IL165511A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN489CH2002 2002-06-27
IN493CH2002 2002-06-28
PCT/US2003/020250 WO2004002982A2 (fr) 2002-06-27 2003-06-27 Procede de preparation de composes sulfoxyde optiquement purs ou optiquement enrichis, notamment de l'esomeprazole amorphe et ses sels

Publications (1)

Publication Number Publication Date
IL165511A0 true IL165511A0 (en) 2006-01-15

Family

ID=34196283

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16551104A IL165511A0 (en) 2002-06-27 2004-12-02 A process for preparing sulfoxide compounds compounds prepared thereby and pharmaceutical compositions containing the same

Country Status (4)

Country Link
US (1) US7169793B2 (fr)
EP (1) EP1515963B1 (fr)
IL (1) IL165511A0 (fr)
WO (1) WO2004002982A2 (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158574A (en) * 1987-07-20 1992-10-27 Regen Corporation Prosthetic meniscus
US5007934A (en) * 1987-07-20 1991-04-16 Regen Corporation Prosthetic meniscus
EA200500673A1 (ru) * 2002-10-22 2005-12-29 Рэнбакси Лабораториз Лимитед Аморфная форма соли эзомепразола, способ ее получения и фармацевтическая композиция на её основе
ATE508124T1 (de) * 2003-03-24 2011-05-15 Eisai R&D Man Co Ltd Verfahren zur herstellung von amorphem rabeprazole-natrium-salz
DE602004022337D1 (de) 2004-04-28 2009-09-10 Hetero Drugs Ltd Verfahren zur herstellung von pyridinylmethyl-1h-benzimidazolverbindungen in enantiomerenangereicherter form oder als einzelne enantiomere
ES2338556T3 (es) 2004-05-28 2010-05-10 Hetero Drugs Limited Sintesis estereoselectiva novedosa de sulfoxidos de benzimidazol.
US20050267159A1 (en) * 2004-05-28 2005-12-01 Aaipharma, Inc. Magnesium complexes of S-omeprazole
MXPA06015031A (es) * 2004-06-24 2007-02-08 Astrazeneca Ab Nuevo proceso para la preparacion de modificaciones cristalinas para usarse en la preparacion de sal de sodio de esomeprazol.
WO2006024890A1 (fr) * 2004-08-30 2006-03-09 Apollo International Limited Procede ameliore de preparation de rabeprazole sodique sous forme amorphe
CN101111233A (zh) 2004-12-23 2008-01-23 兰贝克赛实验室有限公司 稳定的口服苯并咪唑组合物及其制备方法
ES2259269B1 (es) 2005-03-03 2007-11-01 Esteve Quimica, S.A. Procedimiento para la preparacion de derivados de 2-(2-piridilmetilsulfinil)-bencimidazol opticamente activos.
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
US7563812B2 (en) 2005-06-15 2009-07-21 Hetero Drugs Limited Amorphous esomeprazole hydrate
KR100641534B1 (ko) 2005-07-28 2006-11-01 한미약품 주식회사 에스오메프라졸 및 그의 염의 제조방법
US20070043085A1 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of amorphous form of neutral esomeprazole
EP1948637A4 (fr) * 2005-11-14 2010-09-08 Hetero Drugs Ltd Procédé d'obtention d'ésoméprazole amorphe
DE102005061720B3 (de) * 2005-12-22 2006-10-19 Ratiopharm Gmbh Enantioselektive Herstellung von Benzimidazolderivaten und ihren Salzen
EP1801110A1 (fr) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Sel d'arginine d'ésoméprazole
US7553857B2 (en) * 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
CH698658B1 (de) * 2006-04-24 2009-09-30 Mepha Ag Orale pharmazeutische Formulierung mit schneller Freisetzung für Pyridylmethylsulfinyl-Benzimidazole.
US7786309B2 (en) * 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
WO2008004245A1 (fr) 2006-07-05 2008-01-10 Lupin Limited Procédé pour la préparation d'énantiomères optiquement purs ou optiquement enrichis de composés sulfoxydes
JP2010519284A (ja) 2007-02-21 2010-06-03 シプラ・リミテッド エソメプラゾールマグネシウム二水和物の調製方法
KR101303813B1 (ko) * 2007-04-16 2013-09-04 에스케이케미칼주식회사 라세믹 오메프라졸로부터 에스오메프라졸의 개선된제조방법
EP2152691B1 (fr) * 2007-06-07 2011-11-23 Aurobindo Pharma Limited Procédé amélioré pour préparer un inhibiteur de la pompe à protons optiquement actif
EP2106397B1 (fr) 2007-09-25 2011-11-16 Hetero Drugs Limited Procédé de préparation d'ésoméprazole pur sur le plan énantiomère
US8106210B2 (en) 2007-10-08 2012-01-31 Hetero Drugs Limited Polymorphs of esomeprazole salts
US8911787B2 (en) 2008-02-26 2014-12-16 Ranbaxy Laboratories Limited Stable oral benzimidazole compositions and process of preparation thereof
WO2009145368A1 (fr) * 2008-05-27 2009-12-03 Sk Chemicals Co., Ltd. Procédé amélioré de préparation de (s)-oméprazole à partir d'un racémate d'oméprazole à l’aide d'un agent de résolution optique
WO2010058409A2 (fr) 2008-11-18 2010-05-27 Hetero Research Foundation Purification optique d'esoméprazole
CZ2009172A3 (cs) * 2009-03-17 2010-09-29 Zentiva, K.S. Zpusob výroby (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazolu
US20120107248A1 (en) * 2009-07-08 2012-05-03 Mayo Foundation For Medical Education And Research Imaging gastrointestinal volumes and motility
EP2499125B1 (fr) 2009-11-12 2016-01-27 Hetero Research Foundation Procédé de dédoublement de l'oméprazole
KR20120114356A (ko) 2010-02-12 2012-10-16 에스티브 퀴미카 에스.에이. 에스오메프라졸 나트륨염의 제조공정
FR2959509B1 (fr) 2010-05-03 2012-07-13 Prod Chim Auxiliaires Et De Synthese Phase precurseur et son utilisation pour preparer le sel de magnesium tetrahydrate d'un enantiomere d'omeprazole
CA2824063C (fr) 2011-01-09 2020-02-18 Anp Technologies, Inc. Agregats polymeres ramifies induits par des molecules hydrophobes et leur utilisation
CN102321071B (zh) * 2011-07-20 2013-01-23 江苏奥赛康药业股份有限公司 一种高纯度埃索美拉唑钠的工业化生产方法
CN102321072B (zh) * 2011-08-08 2013-07-03 天津市汉康医药生物技术有限公司 埃索美拉唑钠半水化合物
CN102964337A (zh) * 2012-12-20 2013-03-13 南京洵安医药科技有限公司 高光学纯度埃索美拉唑生产方法
EP2929885A1 (fr) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Combinaisons pharmaceutiques de rivaroxaban et d'inhibiteurs de la pompe à protons
EP2933002A1 (fr) 2014-04-11 2015-10-21 Sanovel Ilac Sanayi ve Ticaret A.S. Compositions pharmaceutiques comprenants de dabigratan et des inhibiteurs de la pompe à protons
CN104447737A (zh) * 2014-11-05 2015-03-25 沈阳化工大学 一种泰妥拉唑的手性拆分分离方法
CN111635393A (zh) * 2020-06-28 2020-09-08 江苏吴中医药集团有限公司 一种艾司奥美拉唑钠的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
SE510666C2 (sv) 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE510650C2 (sv) 1997-05-30 1999-06-14 Astra Ab Ny förening
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262085B1 (en) * 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same

Also Published As

Publication number Publication date
WO2004002982A3 (fr) 2004-06-10
WO2004002982A2 (fr) 2004-01-08
EP1515963A2 (fr) 2005-03-23
US7169793B2 (en) 2007-01-30
EP1515963B1 (fr) 2007-02-14
US20040077869A1 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
IL165511A0 (en) A process for preparing sulfoxide compounds compounds prepared thereby and pharmaceutical compositions containing the same
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
IL164798A0 (en) Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
AU2003239302A1 (en) Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
HUP0203766A3 (en) 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them
AU2003291103A8 (en) Pharmaceutical composition
ZA200500683B (en) Agrochemical compositions containing phosphite and process for the preparation thereof
IL164547A0 (en) Pharmaceutical composition
AU2003276549A1 (en) Pharmaceutical compositions containing a biguanide-glitazone combination
IL165012A0 (en) (S)-4-Amino-5-chloro-2-methoxy-N-Ä1-(-tetrahydrofurylcarbonyl)-4-piperidinylmethylÜ-4-piperidinylÜbenzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
PL394600A1 (pl) Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
AU2003231920A8 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
AP1826A (en) A controlled release pharmaceutical composition and a process for preparing the same
HK1049159B (zh) 新的茚並吲哚酮化合物，其製備方法和含有這種化合物的藥物組合物
HK1065477A1 (en) Pharmaceutical composition
HK1049000B (zh) 異吲並吲酮化合物、它們的製備方法和含有它們的藥物組合物
HK1053646A1 (en) BenzoÄBÜpyranoÄ3,2-HÜacridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them
EP1556364A4 (fr) Derives d'isothiazole, procede permettant leur preparation et composition pharmaceutique contenant ces derives
SG110170A1 (en) New benzoindoline compounds, a process for their preparation and pharmaceutical compositions containing them
EP1515960A4 (fr) Derive de 2-thioxothiazole, procede de preparation de ce derive et composition pharmaceutique contenant ce derive
EP1506180A4 (fr) Derive de thiazolidine-4-one, procede d'elaboration, et composition pharmaceutique a base de ce derive
AU2003232684A8 (en) Pyrazole-3-one derivative, method for preparing the same, and pharmaceutical composition containing the same
HUP0201992A3 (en) Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing the compounds and their use
HK1063320A1 (en) New imidazoline compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200302392B (en) Indoline compounds, a process for their preparation and pharmaceutical compositions containing them.